Ionis Pharmaceuticals, Inc. (IONS)

NASDAQ: IONS · Real-Time Price · USD

54.01

+0.62 (1.16%)

At close: Jul 22, 2026, 4:00 PM EDT

53.81

-0.20 (-0.37%)

Pre-market: Jul 23, 2026, 8:15 AM EDT

Ionis Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,058	943.71	705.14	787.65	587.37	810.46
Revenue Growth (YoY)	47.53%	33.83%	-10.47%	34.10%	-27.53%	11.13%
Cost of Revenue	17.43	15.91	11.22	9.13	14.12	10.84
Gross Profit	1,041	927.8	693.92	778.51	573.25	799.61
Selling, General & Admin	467.98	393.87	267.47	232.62	150.3	186.35
Research & Development	925.03	915.62	901.53	899.63	833.15	643.45
Total Operating Expenses	1,393	1,309	1,169	1,132	983.44	829.8
Operating Income	139.82	-381.68	-475.08	-353.73	-410.19	-30.19
Interest Income	98.58	97.77	107.02	89.04	25.33	10.04
Interest Expense	-90.11	-90.54	-90.45	-81.46	-8.12	-9.35
Other Non-Operating Income (Expense)	11.6	-5.14	-1.56	12.18	135	0.34
Total Non-Operating Income (Expense)	20.07	2.08	15.01	19.77	152.21	1.04
Pretax Income	31.22	-379.6	-460.07	-333.97	-257.99	-29.15
Provision for Income Taxes	0.22	1.79	-6.17	32.32	11.74	-0.55
Net Income	123.55	-381.39	-453.9	-366.29	-269.72	-28.6
Net Income to Common	123.55	-381.39	-453.9	-366.29	-269.72	-28.6
Shares Outstanding (Basic)	161	160	150	143	142	141
Shares Outstanding (Diluted)	167	160	150	143	142	141
Shares Change (YoY)	9.44%	7.02%	4.42%	0.95%	0.59%	1.01%
EPS (Basic)	-1.99	-2.38	-3.04	-2.56	-1.90	-0.20
EPS (Diluted)	-2.07	-2.38	-3.04	-2.56	-1.90	-0.20
Free Cash Flow	-971.26	-320.03	-546.23	-331.32	-290.09	18.84
Free Cash Flow Growth	-	-	-	-	-	2340.93%
Free Cash Flow Per Share	-5.81	-2.00	-3.65	-2.31	-2.05	0.13
Gross Margin	98.35%	98.31%	98.41%	98.84%	97.60%	98.66%
Operating Margin	13.21%	-40.45%	-67.37%	-44.91%	-69.84%	-3.72%
Profit Margin	11.68%	-40.41%	-64.37%	-46.50%	-45.92%	-3.53%
FCF Margin	-91.78%	-33.91%	-77.46%	-42.06%	-49.39%	2.33%
EBITDA	164.56	-358.99	-453.09	-331.23	-388.09	-10.63
EBITDA Margin	15.55%	-38.04%	-64.26%	-42.05%	-66.07%	-1.31%
EBIT	139.82	-381.68	-475.08	-353.73	-410.19	-30.19
EBIT Margin	13.21%	-40.45%	-67.37%	-44.91%	-69.84%	-3.72%
Effective Tax Rate	0.70%	-0.47%	1.34%	-9.68%	-4.55%	1.89%

SEC Filings: 10-K · 10-Q